Abstract:Duck circovirus (DuCV) is one of the most prevalent viruses in the duck breeding industry, and causes persistent infection and severe immunosuppression. Currently, there is a serious lack of prevention and control measures and no commercial vaccine against DuCV. Therefore, effective antiviral drugs are important for treating DuCV infection. Interferon (IFN) is an important component of antiviral innate immunity, but it remains unclear whether duck IFN-α has a clinical effect against DuCV. Antibody therapy is an important way to treat viral infections. The DuCV structural protein (cap) is immunogenic, and it remains to be determined whether an anti-cap protein antibody can effectively block DuCV infection. In this study, the duck IFN-α gene and the DuCV structural protein cap gene were cloned, expressed and purified in Escherichia coli to prepare duck recombinant IFN-α and the cap protein. Then, rabbits were immunized with the recombinant cap protein to prepare a rabbit polyclonal antibody. This study investigated the antiviral effect of duck recombinant IFN-α and the anti-cap protein antibody and their combined effect on Cherry Valley ducks infected with DuCV. The results showed that the treatment significantly alleviated the clinical symptoms of immune organ atrophy and immunosuppression compared with the control. The histopathological damage of the target organs was alleviated, and replication of DuCV in the immune organs was significantly inhibited. The treatment also reduced the damage caused by DuCV to the liver and immune function, and increased the level of the DuCV antibody in the blood, thereby improving antiviral activity. Notably, the combination of duck IFN-α and the polyclonal antibody completely blocked DuCV infection after 13 days under the experimental conditions, showing a better inhibitory effect on DuCV infection than single treatments. These results showed that duck recombinant IFN-α and the anti-cap protein antibody can be used as antiviral drugs to clinically treat and control DuCV infection, particularly the vertical transmission of the virus in breeding ducks.

IFN-γ Increases Efficiency of DNA Vaccine in Protecting Ducks Against Infection

Effects of DNA vaccines coadministered with DuIFN-γ expression plasmid on protection of ducks from DHBV infection

Enhancement of the Immunogenicity of DNA Vaccine Against Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin 2.

Immunoenhancement on DNA Vaccine of Polyprotein Gene in Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin-18.

Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.

Immunoenhancement on IBDV DNA vaccine by embryo vaccination with plasmid DNA encoding chicken interleukin-18

Induction of Protective Immune Response in Chickens Immunized with Plasmid DNA Encoding Antigens of Infectious Bursal Disease Virus

[Enhanced Immunogenicity of Plasmid Encoding Polyprotein Gene of Infectious Bursal Disease Virus by Co-Administration of Chicken Interleukin 2 (IL-2)].

Quantitation of IFN-γ Mrna in Duck PBMC and Its Application

[Combination of Lamivudine with Thymosin Alpha1 in Treatment of Duck Hepatitis B].

Synergistic Effects of Adjuvants Interferon-Gamma and Levamisole on Dna Vaccination Against Infection with Newcastle Disease Virus

Cloning and Expression of Chinese Duck Interferon-Gamma Gene

Duck CD40L as an adjuvant enhances systemic immune responses of avian flavivirus DNA vaccine

Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck

Effect of duck interferon-α and an anti-cap protein polyclonal antibody against duck circovirus

Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation

Adjuvant effect of CD40 on H5N1 DNA vaccine in mice

[The Interferon System in Ducks Infected with Viral Hepatitis B].

Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs

Recombinant Vaccinia Virus Expressing Pre-S/S Protein of Duck Hepatitis B Virus and Its Preliminary Use for Treatment of Persistent Infection.

Oral DNA vaccine adjuvanted with cyclic peptide nanotubes induced a virus-specific antibody response in ducklings against goose parvovirus